⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FLNA News
Filana Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
FLNA
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
globenewswire.com
FLNA
Form 8-K
sec.gov
FLNA
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
globenewswire.com
FLNA
Form 8-K
sec.gov
FLNA
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
FLNA
Form 8-K
sec.gov
FLNA
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
globenewswire.com
FLNA
Form 8-K
sec.gov
FLNA
Form 8-K
sec.gov
FLNA